We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Anticancer Therapies – Products

Avacta Group Plc Announces SARS-CoV-2 Rapid Antigen Test Update content piece image
Product News

Avacta Group Plc Announces SARS-CoV-2 Rapid Antigen Test Update

Avacta Group plc announces significant progress in the development of a highly scalable manufacturing process for a lateral flow SARS-CoV-2 antigen test.
PhoreMost and Oxford Biomedica Enter Gene Therapy Discovery Collaboration content piece image
Product News

PhoreMost and Oxford Biomedica Enter Gene Therapy Discovery Collaboration

PhoreMost Limited and Oxford Biomedica plc today announced that they have entered into a discovery collaboration to develop next-generation CAR-T cell therapies.
New Study Demonstrates Effective HemoScreen Evaluation of Acute Leukemia Patients content piece image
Product News

New Study Demonstrates Effective HemoScreen Evaluation of Acute Leukemia Patients

PixCell Medical, innovator of rapid diagnostic solutions at the point-of-care, announced today the results of a new study published in the International Journal of Laboratory Hematology demonstrating that the company’s HemoScreen™ point-of-care hematology analyzer is suitable for the evaluation and management of patients receiving chemotherapy treatment for hematological cancers.
Biopharma Receives Positive EMA Opinion on Orphan Designation for Pancreatic Cancer Treatment content piece image
Product News

Biopharma Receives Positive EMA Opinion on Orphan Designation for Pancreatic Cancer Treatment

Prestige BioPharma Ltd. (hereinafter “Prestige BioPharma”) today announced that the European Medicines Agency (EMA) Orphan Drug Commission (COMP) has granted a positive opinion for an Orphan Drug Designation (ODD) status to its first-in-class anti-PAUF monoclonal antibody, PBP1510, for the treatment of pancreatic cancer.
App Note / Case Study

Annotation of Saponins in Chinese Medicines Using Structure-Based MS

Despite possessing numerous advantageous pharmacological properties, the comprehensive annotation of saponins remains challenging. Download this app note to discover how a structure-based mass spectrometry workflow can be used.
My Personal Therapeutics and Pentavere Receive EUREKA Funding to Support AI-based Personalized Cancer Treatment Plans content piece image
Product News

My Personal Therapeutics and Pentavere Receive EUREKA Funding to Support AI-based Personalized Cancer Treatment Plans

My Personal Therapeutics and Pentavere have announced their successful EUREKA Collaborative R&D: AI and Quantum Technologies Competition award for project titled "Utilisation of AI to develop Personalised Treatment Plans for cancer".
Intravacc to In-license CimCure’s iBoost Technology content piece image
Product News

Intravacc to In-license CimCure’s iBoost Technology

Intravacc has announced the signing of a strategic partnership agreement with Dutch-based CimCure for in-licensing CimCure’s iBoost technology.
Dante Labs, Cambridge Cancer Genomics and Nonacus Collaborate to Provide Precision Oncology at Scale content piece image
Product News

Dante Labs, Cambridge Cancer Genomics and Nonacus Collaborate to Provide Precision Oncology at Scale

The partnership aims to deliver a comprehensive, cost effective and high throughput cancer sequencing and interpretation service to enable improved cancer patient management, treatment, and monitoring.
Sygnature Acquires Alderley Oncology to Strengthen Oncology Drug Testing Capabilities content piece image
Product News

Sygnature Acquires Alderley Oncology to Strengthen Oncology Drug Testing Capabilities

Sygnature Discovery has further strengthened its oncology and immuno-oncology capabilities with the acquisition of Alderley Oncology.
Thermo Fisher Scientific and Q2 Solutions Partner to Deliver Clinical Trial Results Faster content piece image
Product News

Thermo Fisher Scientific and Q2 Solutions Partner to Deliver Clinical Trial Results Faster

Q2 Solutions has announced its partnership with Thermo Fisher Scientific to deliver clinical trial lab results economically with unprecedented speed.
Advertisement